Working with Industry Delivering innovative research through effective partnerships Photograph © Rob Sparkes Collaboration for Leadership in Applied Health Research and Care Yorkshire and Humber Welcome to the NIHR CLAHRC YH Industry Briefing This briefing showcases not only our ways of working with industry partners but also how we are having an impact locally and nationally. The CLAHRC Vision is to understand health care and health service needs and how they can be addressed and transformed by digital technologies as we strive to achieve the three key aims of the NHS safety, quality and cost effective care (Delivering the benefits of Digital Health Care 2016) www.nuffieldtrust.org.uk/research/delivering-the-benefits- of-digital-health-care The new Government Green paper ‘Building Our Industry Strategy’ January 2017 www.gov.uk/ government/consultations/ building-our-industrial-strategy clearly identifies that a ‘modern industrial strategy is a critical part of our plan for post-Brexit Britain’ suggesting ‘a fairer society where wealth and opportunity are spread across every community in the United Kingdom not just the most prosperous places in London and the South East’. The Green paper proposes investment in science, research and innovation across all sectors through a new ‘Industry Strategy Challenge fund’. This view of a need to invest in applied health services and public health research in the populations most affected by disease burden and social deprivation was voiced recently in a letter entitled ‘shaping the future of NIHR’ from Professor Chris Whitty and Dr Louise Wood, with a clear view to balance NIHR research and innovation resources across the country. Both policy initiatives support the vision of our NIHR CLAHRC in Yorkshire and Humber where we have, for many years, sought to address health inequalities and the significant burden of chronic disease populations through the integration of new innovative digital technologies and in partnership with the medical technology sector. Our success and impact in this area is evidenced both by external evaluations, and also by ongoing feedback from the National Institute for Health Research (NIHR), which has commended us on our partnerships with patients, the public and industry. I am confident that our work with new and emerging technology, is helping us to address the chronic disease burden and social deprivation that is our Industrial Heritage legacy. Professor Sue Mawson Director, NIHR CLAHRC Yorkshire and Humber 1 Collaboration for Leadership in Applied Health Research and Care Yorkshire and Humber Background With the publication of: Our NIHR CLAHRC’s industry engagement enables the • ‘Innovation, Heath and Wealth: Accelerating private sector to capitalise on the great medical and adoption and diffusion in the NHS’ Department of clinical expertise housed within the region’s universities Health in Dec 2011 and research centres. We also seek to ensure patients have access to the latest research through our citizen • Academic Health Science Networks (AHSNs) cohorts enabling better outcomes for patients and a designation guidelines more person centre design and development focus. • Government Green paper ‘Building Our Industry Our range of offers to industry includes supporting: Strategy’ Jan 2017 • the development of partnerships between industry and the development of the Northern Health Science and NHS/Local Authorities Alliance www.thenhsa.co.uk, it has become even more apparent that the government’s wealth and growth • the implementation and evaluation of evidence agenda is clearly linked to closer partnerships between based technologies for chronic disease management the NHS, academia and industry. and end of life care In Yorkshire and Humber our portfolio includes a range • access to health economics research and new of high value, high trust industrial collaborators from models of care using existing technologies global, national small and medium-sized enterprises • validation of technology need through stakeholder (SMEs). Our focus has been to work with industrial scoping partners that align with our research themes and our • the contextualising of existing technologies for core objectives; hence we have focussed more on different environments the medical device and technology sector, and on delivering the benefits of digital health care. Given that • use of participatory design methodologies in the Pharma sector is beginning to explore the role of partnership with industry medical devices within its portfolio of service offerings, • applications for new funding streams for we will keep a watching brief for potential future partnerships and Knowledge Transfer with industry partners. Each of these activities helps to ensure that the NHS The medical technology market is estimated to be and Local Authorities have access to technology worth £150-170bn worldwide, with growth rates solutions. Therefore enabling a transformation in forecast at 10% a year over the next five years and a the way they work to improve the quality, safety, market size approaching £300bn by 2015. It is a sector productivity and cost effectiveness of care. For industry that is growing rapidly in the UK, with more than 3,000 these initiatives help ensure that their products and companies that generate around £15bn in turnover services address real needs and that their solutions are http://bit.ly/2m2skUW. fit for purpose and affordable. Yorkshire and Humber is perfectly positioned for growth - with NHS England based in this region, a strong base of medtech and technology enabled care firms and coterminous NIHR CLAHRC YH and the YH AHSN resources to spearhead the use of innovative products and services in the NHS. The NHS Five Year Forward View (5YFV) and National Information Board’s paper on Personalised Health and Care 2020 highlight that digital technology plays a key role in all three elements in the 5YfV: public health, quality of care and efficiency. It will help ensure best value for the tax payer. More importantly these policy documents also state digital technologies will be more tightly embedded in NHS policy, finance and regulation. Delivering innovative research through effective partnerships 2 Objectives NHS England recognises that without the effective This is not to say that we will not engage with a much use of new technologies the NHS will fail to deliver broader range of industry representatives. We see on its commitments in years to come. With this in the relationships with our stakeholders as being vital mind, NIHR CLAHRC YH has developed an Industry to our impact agenda, raising awareness of the full Strategy that focuses on the medtech and medical range of NIHR CLAHRC YH activities, our core mission devices sector. We believe this is the area that has the and underlying principles. Engaging with industry most potential to change the nature of health care, and community is a dialogue. A key feature of our promoting wealth, improving health and building on ambition is for NIHR CLAHRC YH to increasingly act as the extensive work in this sector over the past five a ‘meeting place’ and facilitator for industry and other years in YH and within our partner organisations. stakeholders with an interest in mutual interaction, but By wealth, we mean the impact our collaboration who would not readily come into contact with each can have working with industry to support the other or with leading academic researchers. implementation of a cost effective health service We have close relationships with both the YH AHSN through new models of care and the integration of and the Devices for Dignity (D4D) Health Technologies digital capabilities into new care pathways. This is Co-operative (HTC). Collaboration with the YH AHSN alongside the direct benefits of attracting research has included the development of an evaluation funding and industry into the region. offer for the Vanguards and the sustainability and NIHR CLAHRC YH measures the success of its transformation plans (STPs), thereby supporting new industry engagement on building a small number government policies regionally. From an industry of very high value relationships. We work closely perspective the link between the YH AHSN and with a wide range of collaborators to identify and NIHR CLAHRC YH is through the Telehealth and Care understand industry needs, match industry needs Technology Theme. The collaboration with D4D, with academic research interests and capability, also hosted at Sheffield Teaching Hospitals NHS FT, whilst managing our established partnerships to allows us to work together on the innovation pathway ensure mutually beneficial and successful outcomes. directing industry partners accordingly. 3 Collaboration for Leadership in Applied Health Research and Care Yorkshire and Humber CLAHRC Match linked to Financial Model industry 2015/2016 CLAHRCs were the first NIHR initiative that followed Proportion of match by source the Canadian model of health academies (Lomas, J., 2007. The in-between world of knowledge brokering. BMJ: British Medical Journal, pp.129-132) with a Charitable sector matched funding requirement to build on the funding Local authorities provided by the NIHR contract. The match funding Industry needs to be at least to the level of the NIHR award (match £ for £), each CLAHRC needing to achieve The NHS a portfolio of £10 million match over the five year Universities period in order to drawdown funds from NIHR. This model offers the opportunity for collaborating organisation to provide match funding